Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) EBT Margin (2018 - 2025)

TransMedics has reported EBT Margin over the past 8 years, most recently at 52.7% for Q4 2025.

  • Quarterly results put EBT Margin at 52.7% for Q4 2025, down 5844.0% from a year ago — trailing twelve months through Dec 2025 was 0.19% (down 791.0% YoY), and the annual figure for FY2025 was 0.19%, down 791.0%.
  • EBT Margin for Q4 2025 was 52.7% at TransMedics, down from 16.01% in the prior quarter.
  • Over the last five years, EBT Margin for TMDX hit a ceiling of 370.63% in Q4 2021 and a floor of 239.29% in Q3 2021.
  • Median EBT Margin over the past 5 years was 4.09% (2023), compared with a mean of 14.17%.
  • Biggest five-year swings in EBT Margin: skyrocketed 45438bps in 2021 and later crashed -39278bps in 2022.
  • TransMedics' EBT Margin stood at 370.63% in 2021, then plummeted by -106bps to 22.16% in 2022, then soared by 121bps to 4.76% in 2023, then rose by 21bps to 5.75% in 2024, then tumbled by -1017bps to 52.7% in 2025.
  • The last three reported values for EBT Margin were 52.7% (Q4 2025), 16.01% (Q3 2025), and 22.99% (Q2 2025) per Business Quant data.